Global Neuroprotective Agents Market Intelligence Report Offers Growth Prospects To 2022| Bayer Healthcare, Eisai, Glaxosmithkline, Merck Serono SA, Novartis Ag
According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimers disease, epilepsy, Parkinsons disease (PD), brain injuries, and glaucoma and other eye disorders. Nearly 7 million people died from these diseases. According to the report, one in six people is stricken by a neurological disorder every year, many of them becoming seriously disabled.
Get Free PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1823511
In 2015, neurological disorders ranked as the leading cause of lifelong disabilities among the main disease groups and were the second most common cause of death. Stroke is the leading neurological disorder and it affects more than 15 million people every year worldwide, killing 5 million people and leaving an equal number of people with debilitating disabilities.
In 2015, AD affected more than 46 million people, and it was the second leading cause of death, after stroke. Neurodegenerative disorders such as AD, PD, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) ranked in the 10 most fatal incurable diseases.
As life spans increase, most of the neurological disorders are becoming more prevalent. Common diseases of advanced age such as glaucoma, AD-associated dementia, age-related macular degeneration (AMD), diabetic retinopathy and PD affect nearly one-fourth of adults over 60.
In the U.S., 1.5 million people suffer from a traumatic central nervous system (CNS) injury each year. This number consists primarily of young adults and the elderly, due to reasons such as accidents, falls, sports- and work-related injuries, combat and self-harm. One-third of injury-related deaths in the U.S. are caused by traumatic brain injuries, which also lead to serious physical disabilities, cognitive disorders and neurodegenerative diseases.
Treating neurological disorders has proved to be greatly challenging. In addition to mostly insufficient clinical research in many neurological disorders, therapeutic limitations are due to a natural protective seal around the brain called the blood-brain barrier, which makes it extremely difficult to effectively diffuse a drug compound into the brain.
Neuroprotection is an approach to the treatment of neurological disorders through the use of therapies that are developed by learning from the brains own tools to protect nerve cells from damage, degeneration and death. The human brain, by large and small biological molecules and certain types of cells, can promote growth, survival and differentiation to adapt to sudden changes, trauma and disease. Neuroprotective agents in global markets and clinical pipelines include small molecule drugs, therapeutic monoclonal antibodies, gene therapies, cell therapies and other agents.
The global market for neuroprotective agents was valued at $REDACTED billion in 2016 and $REDACTED billion. in 2017
The scope of this report covers the global market for small molecule drugs, monoclonal antibodies, gene and cell therapies, and other biotechnology products that are approved or being developed for the treatment of neurological disorders.
Therapeutic indications are grouped under four categories: cerebrovascular diseases, neurodegenerative disorders, ophthalmic diseases and traumatic CNS injuries. Indication subcategories include stroke, Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, multiple sclerosis, Huntingtons disease, spinal muscular atrophy, epilepsy, glaucoma, age-related macular degeneration, optic neuropathies, diabetic retinopathy and traumatic brain and spinal cord injuries. The report does not cover the neuroprotective agents that are used for protecting the brain during risky neurosurgeries and other general operations.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=1823511
- 39 tables
- An overview of the global market for neuroprotective agents and their therapeutic applications
- Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Market breakdowns by indication, mechanism of action, and by region
- Discussion of various neurodegenerative disorders
- Profiles of key companies in the market, including Bayer Healthcare, Eisai Inc., Glaxosmithkline Plc, Merck Serono S.A., Novartis Ag and Teva Pharmaceutical Industries Ltd.
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States,
USA-Canada Toll Free: 866-997-4948,
Follow me on : https://marketinfo247.wordpress.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Neuroprotective Agents Market Intelligence Report Offers Growth Prospects To 2022| Bayer Healthcare, Eisai, Glaxosmithkline, Merck Serono SA, Novartis Ag here
News-ID: 1725047 • Views: 1322
More Releases from Neuroprotective Agents Market
Emerging Trends Neuroprotective Agents Market Analysis Revenue and Market Share …
Researchmoz has announced the addition of the “Neuroprotective Agents: Therapeutic Applications and Global Markets"report to their offering "Summary According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimers disease, epilepsy, Parkinsons disease (PD), brain injuries, and glaucoma and other eye disorders. Nearly 7 million people died from these diseases. According to the report, one
Global Neuroprotective Agents Market to 2022| Bayer Healthcare, Eisai Inc, Glaxo …
Albany, NY, 10th August : Recent research and the current scenario as well as future market potential of "Neuroprotective Agents: Therapeutic Applications and Global Markets" globally. According to the 2007 Global Burden of Disease report from the World Health Organization (WHO), more than 1 billion people worldwide suffered from neurological disorders, including stroke, Alzheimers disease, epilepsy, Parkinsons disease (PD), brain injuries, and glaucoma and other eye disorders. Get PDF for more Professional
More Releases for Albany
Global Outbuildings Market 2018 - Suncast, Palram, Albany, OLT
Apex Market Reports, recently published a detailed market research study focused on the “Outbuildings Market” across the global, regional and country level. The report provides 360° analysis of “Outbuildings Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Outbuildings on the basis of
Global Outbuildings Market 2018 - Lifetime, Arrow Sheds, Suncast, Palram, US Pol …
The global Outbuildings market accounted at US$ XX million for the present year, it was predicted this market will reach to US$ XX million by 2025. It is projected that the global Outbuildings market is expected to grow at a CAGR of XX%. The report provides detailed analysis of global and regional market. In 2018 North America XX market was expected to reach at US$ XX million. Request for the sample
Tea is the most consumed beverage worldwide next to water. There have been various shifts in the history of tea culture in the United States. Recently, a research report “Tea and RTD Tea - US Market Research Reports - August 2017” has been added to Market Research hub (MRH)’s database. According to the report, tea and RTD market has grown by 24% between 2012-2017. The report also provides an insight into
Know More About Visit Albany GA Attractions, Hotels and Restaurants
Date: November 24, 2016 Location:112 North Front Street, Albany, GA 31701 Contact Number: 229-317-4760 Email: firstname.lastname@example.org Websites: http://visitalbanyga.com Albany is the city in Georgia and is in close proximity to Columbus, Savannah and Atlanta. The city is rich in heritage, culture, natural beauty and also theatre. Whether it is having breakfast with cheetahs out in their habitat or watching a play or predicting the climate conditions of the city in the weather center, this place
Enjoy Delicious Food at Albany GA Restaurants
Date :- 27 to 28 October, 2016 Location :- 112 North front street, Albany, Ga 31701 Contact No. :- 229-317-4760 Website:- http://visitalbanyga.com Email :- email@example.com Located in the southern Georgia the Albany is a small town along with the big personality. Their boasting as music legend Ray Charles as this one of the sons and tree-lined streets or historic buildings can provide by backdrop for that classic Southern dishes as well as soulful for southern
Know Everything You Need to About Albany GA Attractions
Date : 31 August 2016 Location : 112 North Front Street Albany, GA 31701 Contact Number : 229-317-4760 Toll-Free : 866-750-0840 Email : firstname.lastname@example.org Web Site : http://visitalbanyga.com Albany is one of the cities of Georgia and is prominent because of its cultural importance. It is an interesting place to visit and view some of the best architectural designs from the history including modern Empire State Plaza. It is the longest chartered city in the United States.